Request Deal Involvement
A consortium of investors led a $300m Series C funding round in Tessera Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Salutem
legal advisors
Gibson Dunn & Crutcher
legal advisors
White & Case
or
Principals
target
TESSERA THERAPEUTICS
bidder
ABU DHABI INVESTMENT AUTHORITY (ADIA)
bidder
ALASKA PERMANENT FUND CORPORATION
bidder
ALTITUDE LIFE SCIENCE VENTURES
bidder
ARTIS VENTURES
bidder
CORMORANT ASSET MANAGEMENT
bidder
FLAGSHIP PIONEERING
bidder
HANWHA IMPACT PARTNERS
bidder
LONGEVITY VISION FUND
bidder
MARCH CAPITAL PARTNERS
bidder
SALT FUND
bidder
SOFTBANK VISION FUND 2
bidder
T. ROWE PRICE GROUP INC
bidder
QATAR INVESTMENT AUTHORITY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite